
    
      This is a clinical study to assess the treatment (efficacy and toxicity) with a high dosed
      chemotherapy followed by stem cell transplantation in patients suffering from primary
      progressive and relapsed aggressive Non-Hodgkin Lymphoma (NHL)

      After end of the active study phase, patients will receive further standard medical care at
      the discretion of the treating physician. The clinical consultants will provide advice on
      further treatment if requested.
    
  